Alzheimer's disease and osteoporosis: Common risk factors or one condition predisposing to the other?;Choroba Alzheimera a osteoporoza: Wspólne czynniki ryzyka czy też jedna choroba predysponuje do drugiej?

Ortopedia Traumatologia Rehabilitacja

Volumn 10, Issue 4, 2008, Pages 315-323

  Tysiewicz Dudek, Marzena ^a   Pietraszkiewicz, Franciszek ^b   Drozdzowska, Bogna ^c  

^a Specialist Medical Practice ^*  (Poland)

^b Multispecialty Hospital   (Poland)

^c MEDICAL UNIVERSITY OF SILESIA   (Poland)

Author keywords

Alzheimer's disease; Dementia syndrome; Osteoporosis

Indexed keywords

APOLIPOPROTEIN E4; BISPHOSPHONIC ACID DERIVATIVE; CALCIUM; ESTROGEN; PARATHYROID HORMONE; RISEDRONIC ACID; VITAMIN D; VITAMIN K GROUP;

ALZHEIMER DISEASE; BONE DENSITY; CALCIUM BLOOD LEVEL; CALCIUM INTAKE; COMORBIDITY; DISEASE PREDISPOSITION; FALLING; FEMUR NECK FRACTURE; FRACTURE; GENETIC ASSOCIATION; HUMAN; INCIDENCE; OSTEOPOROSIS; PARATHYROID HORMONE BLOOD LEVEL; REVIEW; RISK ASSESSMENT; RISK FACTOR; RISK REDUCTION; SUN EXPOSURE; VITAMIN BLOOD LEVEL; VITAMIN D DEFICIENCY; VITAMIN K DEFICIENCY;

AGED; ALZHEIMER DISEASE; BONE DENSITY CONSERVATION AGENTS; CALCIUM, DIETARY; CAUSALITY; COMORBIDITY; DIETARY SUPPLEMENTS; EVIDENCE-BASED MEDICINE; FEMALE; FRACTURES, BONE; HUMANS; MALE; MIDDLE AGED; OSTEOPOROSIS; RISK FACTORS; SUNLIGHT; VITAMIN D; VITAMIN D DEFICIENCY;

EID: 56249091793     PISSN: 15093492     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Review

References (40)

1. Kozubski W, Liberski PP. Choroby układu nerwowego. Warszawa, Wydawnictwo Lekarskie PZWL 2004.
2. Badurski JE, Sawicki A, Boczoń S. Osteoporoza. II wyd. Białystok 1994.
3. Lorenc RS, Olszyński WP. Osteoporoza. Poradnik dla lekarzy. II wyd. Warszawa, Biuro Gamma 2006.
4. Weller I, Schatzker J. Hip fractures and Alzheimer's disease in elderly institutionalized Canadians. Ann Epidemiol 2004 May; 14 (5): 319-24.
5. Janti PO, Pyyko VI, Hervonen AL. Falls among elderly nursing home residents. Public Health 1993; 107: 89-96.
6. Myers AH, Young Y, Langlois JA. Prevention of falls in the elderly. Bone 1996; 18: 87S-101S.
7. Cumming RG, Nevitt MC, Cumming RR. Epidemiology of hip fractures. Epidemiol Rev 1997; 19: 244-257.
8. Sato Y, Asoh T, Oizumi K. High prevalence of vitamin D deficiency and reduced bone mass in elderly women with Alzheimer's disease. Bone 1998; 23 (6): 555-557.
9. Chapuy MC, Arlot ME, Duboeuf F, Braun J, Crouzet B, Arnaud, et al. Vitamin D3 and calcium to prevent hip fractures in elderly women. N Engl J Med 1992; 327: 1637-42.
10. Sato Y, Kanoko T, Satoh K, Iwamoto J. Risk factors for hip fracture among elderly patients with Alzheimer's disease. J Neurol Sci 2004; 30; 223 (2): 107-112.
11. Melton LJ III, Beard CM, Kokmen E, Atkinson EJ, O'Fallon WM. Fracture risk in patients with Alzheimer's disease. J Am Geriatr Soc 1995; 43: 454-457
12. Matsueda M, Ishii Y. The relationship between dementia score and ambulatory level after hip fracture in the elderly. Am J Orthop 2000; 29: 691-3
13. Morrison RS, Siu AL. Mortality from pneumonia and hip fractures in patients with advanced dementia JAMA 2000; 284: 2447-8
14. Sato Y, Iwamoto J. Amelioration of osteoporosis and hypovitaminosis D by sunlight exposure in hospitalized, elderly women with Alzheimer's disease: a randomized controlled trial. J Bone Miner Res 2005; 20 (8): 1327-33. Epub 2005 Apr 4.
15. Sato Y, Honda Y, Hayashida N, Iwamoto J, Kanoko T, Satoh K. Vitamin K deficiency and osteopenia in elderly women with Alzheimer's disease. Arch Phys Med Rehabil 2005; 86 (3): 576-81.
16. Kanai T, Takagi T, Masuhiro K, Nakamura M, Iwata M, Saji F. Serum vitamin K level and bone mineral density in postmenopausal women. Int J Gynecol Obstet 1997; 56: 25-30.
17. Jie KS, Bots ML, Vermeer C, Witte JC, Grobbee DE. Vitamin K status and bone mass in women with or without aortic atherosclerosis: a population-based study. Calcif Tissue Int 1996; 59: 352-6.
18. Stein MS, Wark JD, Scherer SC, et al. Falls relate to vitamin D and parathyroid hormone in an Australian nursing home. J Am Geriatr Soc 1999; 47: 1195-201.
19. Wong SY, Lau EM, Li M, Chung T. The prevalence of ApoE4 genotype and its relationship to bone mineral density in Hong Kong Chinese. J Bone Miner Metab 2005; 23 (3): 261-5.
20. Contois JH, Anamani OE, Tsongalis GJ. The underlying molecular mechanisms of apolipoprotein E polymorphism: relationships to lipid disorders, cardiovascular disease and Alzheimer's disease. Clin Lab Med 1996; 16: 105-123.
21. Wilson PW, Myers RH, Larson MG, Ordovars J, Wolf PA, Schaefer EJ. Apolipoprotein E allele, dyslipidemia and coronary heart disease. The Framingham Offspring Study. JAMA 1994; 272: 1666-1671.
22. Shiraki M, Shiraki Y, Aoki C, Hosoi T, Inoue S, Kaneki M, Ouchi Y. Association of bone mineral density with apolipoprotein E phenotype. J Bone Miner Res 1999; 14: 1175-1181.
23. Johnston JM, Cauley JA, Ganguli M. APO E and hip fracture risk in a community-based study of older adults. J Am Geriatr Soc 1999; 47: 1342-1345.
24. Cauley JA, Zmuda JM, Yaffe K, Kuller LH, Ferrell RE, Wisniewski SR, Cumming SR. Apolipoprotein E polymorphism: a new genetic marker of hip fracture risk - the study of osteoporotic fractures. I Bone Miner Res 1999; 14: 1175-1181.
25. Salamone LM, Cauley JA, Zmuda J, Pasagian-Macaulay A, Epstein RS, Ferrell RE, Black DM, Kuller LH. Apolipoprotein E gene polymorphism and bone loss: oestrogen status modified the influence of apolipoprotein E on bone loss. J Bone Mine Res 2000; 15: 308-314.
26. Xu L, Lu A, Zhao X, Chen X, Cummings SR. Very low rates of hip fractures in Beijing, People's Republic of China: the Beijing Osteoporosis Project. Am J Epidemiol 1996; 144: 901-907.
27. Fujiwara NK, Marti B, Gutzwiller F. Hip fracture mortality and morbidity in Switzerland and Japan: across cultural comparison. Soz Prarentivmed. 1993; 38: 8-14.
28. Tan ZS, Seshadri S, Beiser A, Zhang Y. Bone mineral density and the risk of Alzheimer disease. Arch Neurol 2005; 62 (1): 107-11.
29. Fox KM, Magaziner J, Sherwin R, et al. Reproductive correlates of bone mass in elderly women. J Bone Miner Res 1993; 8: 901-908.
30. Heiss CJ, Sanborn CF, Nichols DL, Bonnick SL, Alford BB. Associations of body fat distribution, circulating sex hormones, and bone density in postmenopausal women. J Clin Endocrinol Metab 1995; 80: 1591-1596:
31. Nguyen TV, Jones G, Sambrook PN, White CP, Kelly PJ, Eisman JA. Effects of oestrogen exposure and reproductive factors on bone mineral density and osteoporotic fracture. J Clin Endocrinol Metab 1995; 80: 2709-2714.
32. Bachman DL, Wolf PA, Linn RT, et al. Incidence of dementia and probable Alzheimer's disease in a general population: the Framingham Study. Neurology 1993; 43: 515-519.
33. Jaffe AB, Toran-Allerand CD, Greengard P, Gandy SE. Oestrogen regulates metabolism of Alzheimer's amyloid beta precursor protein. J Biol Chem 1994; 269: 13065-13068.
34. Kawas C, Resnick S, Morrison A, et al. A prospective study of oestrogen replacement therapy and the risk of developing Alzheimer's disease; Baltimore Longitudinal study of Ageing. Neurology 1997; 48: 1517-1521.
35. Tang MX, Jacobs D, Stern Y, et al. Effect of ooestrogen during menopause on risk and age of onset of Alzheimer's disease. Lancet 1996; 348: 429-432.
36. Waring SC, Rocca WA, Petersen RC, O'brien PC, Tangalos EG, Kokmen E. Postmenopausal oestrogen therapy and risk of Alzheimer's disease. Neurology 1999; 52: 965-970.
37. Asthana S, Craft S, Baker LD, et al. Cognitive and neuroendocrine response to transdermal oestrogen in postmenopausal women with Alzheimer's disease: results of placebo-controlled, double-blind study. Psychoneuroendocrinology 1999; 24: 657-677.
38. McNally DN, Kenny AM. Adherence of academic geriatric practitioners to osteoporosis screening guidelines. Osteoporos Int 2007; 18 (2): 177-83. Epub 2006 Oct 17.
39. Aspray TY, Stevenson P, Abdy SE. Low bone mineral density measurements in care home residents - a treatable cause of fractures. Age Ageing 2006; 35 (1): 37-41.
40. Sato Y, Kanoko T, Satoh K, Iwamoto J. The prevention of hip fracture with risedronate and ergocalciferol plus calcium supplementation in elderly women with Alzheimer disease: a randomized controlled trial. Arch Intern Med 2006 22; 166 (10): 1144-45.